Charlotta Liljebris

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Charlotta Liljebris is an author at Uppsala University specializing in solid dispersion formulation, pharmacokinetic enhancement, and pharmacokinetics.

Publications per year

2023–2024

Publications

Despite warnings, co‐medication with proton pump inhibitors and dasatinib is common in chronic myeloid leukemia, but <scp>XS004</scp>, a novel oral dasatinib formulation, provides reduced <scp>pH‐dependence</scp>, minimizing undesirable <scp>drug–drug</scp> interactions

Gunnar Larfors, Per Andersson, Gérald Jesson et al. · European Journal Of Haematology · 2023 · 12 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13

Enhanced Bioavailability and Reduced Variability of Dasatinib and Sorafenib with a Novel Amorphous Solid Dispersion Technology Platform

Hans Lennernäs, Magnus Brisander, Charlotta Liljebris et al. · Clinical Pharmacology in Drug Development · 2024 · 12 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–2 of 2